Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer

doi:10.3748/wjg.15.3855

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3020)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

334

HTML

2194

Figures (1-2)

237

Tables (1-5)

255

Sum=3020

Aug 21, 2009 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 21, 2009; 15(31): 3855-3864
Published online Aug 21, 2009. doi: 10.3748/wjg.15.3855

Table 4 Liver injury by chemotherapy regimen[12]

Regimen	Sinusoidal dilation¹ (n = 22)			Steatosis > 30% (n = 36)			Steatohepatitis² (n = 34)
Regimen	Yes (%)	No (%)	P value³	Yes (%)	No (%)	P value³	Yes (%)	No (%)	P value³
No CT	2	98		9	91		4	96
FU	0	100	NS	17	83	NS	5	95	NS
IRI	4	96	NS	11	89	NS	20	80	0.001
OX	19	81	0.00001	4	96	NS	6	94	NS
Other	0	100	NS	8	92	NS	0	100	NS

¹Rubbia: Brandt grade 2 or 3;

²Kleiner score ≥ 4;

³Presence of liver injury characteristic; comparison of each chemotherapy group vs no chemotherapy. FU: Fluorouracil; IRI: Irinotecan; OX: Oxaliplatin; NS: Not significant.

Citation: Saif MW. Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer. World J Gastroenterol 2009; 15(31): 3855-3864
URL: https://www.wjgnet.com/1007-9327/full/v15/i31/3855.htm
DOI: https://dx.doi.org/10.3748/wjg.15.3855